{
    "nct_id": "NCT06744816",
    "official_title": "Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study",
    "inclusion_criteria": "* Participants diagnosed with pain of the lower extremity from chronic (>90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds), seen at MD Anderson Cancer Center\n* Participants reporting baseline pain â‰¥ 4 (0-10 scale, NRS)\n* Participants age 18+\n* Participants who have completed chemotherapy within the last year at the time of enrollment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants with cognitive dysfunction\n* Participants with recent history (<6 months) of drug or alcohol abuse\n* Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection\n* Participants with allergies to capsaicin or adhesives\n* Pregnant participants",
    "miscellaneous_criteria": ""
}